IRVINE, Calif.– Biotech skincare brand Epicutis has named Dr. James Y. Wang, a prominent Harvard- and UCLA-trained dermatologist, as Chairman of its Scientific Advisory Board. The appointment underscores the company’s continued push for clinically advanced, non-toxic skincare rooted in rigorous science rather than cosmetic trends.
Dr. Wang is a double board-certified dermatologist and dermatopathologist and the founder of Metropolis Dermatology, which operates five clinics across California. With expertise in treating conditions such as skin cancer, psoriasis, eczema, and acne, Wang has built a reputation for championing evidence-based skin therapies. He earned his medical degree from Harvard Medical School and holds an MBA in healthcare policy from Harvard Business School.
“As a physician, my focus has always been on solutions that are safe, effective, and backed by science,” said Dr. Wang. “Epicutis blends biotech innovation with clinical dermatology in a way that’s truly transforming skin health. I’m excited to help steer the brand’s next phase of growth and innovation.”
Epicutis was founded on the scientific work of Princeton biophysicist Dr. Jeffrey Stock and is known for formulating products with proprietary, patented active ingredients. Designed exclusively for use by skincare professionals, the brand emphasizes small-batch production, ingredient transparency, and a strict avoidance of unnecessary additives and stabilizers.
“Dr. Wang’s leadership will be instrumental as we continue raising the standard for clean, science-backed skincare,” said Maxwell Stock, Founder and CEO of Epicutis. “His clinical insight and passion for innovation align with our mission to support skin health over hype—and to offer dermatologists and clinicians truly effective tools that stand apart from mass-market beauty products.”
With Dr. Wang now leading the advisory board, Epicutis plans to expand its research-driven product line while advocating for stronger industry standards around safety and efficacy. The company aims to empower skincare professionals with exclusive, clinical-grade solutions that not only improve patient outcomes but also help practices grow by building trust through results.
Epicutis continues to position itself at the intersection of biotechnology and dermatology—offering more than just products, but a platform for practitioners seeking a science-first approach to skin health.
